CCB
REGN icon

Cutter & Co Brokerage’s Regeneron Pharmaceuticals REGN Stock Holding History

Cutter & Co Brokerage’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,838
Closed -$6.87M – 135
2025
Q1 		$6.87M Buy
10,838
+2,880
+36% +$1.98M 1.63% 15
2024
Q4 		$5.67M Buy
7,958
+293
+4% +$246K 1.38% 16
2024
Q3 		$8.06M Sell
7,665
-111
-1% -$124K 1.82% 8
2024
Q2 		$8.17M Sell
7,776
-50
-0.6% -$48.5K 1.98% 8
2024
Q1 		$7.53M Sell
7,826
-57
-0.7% -$54.2K 1.85% 8
2023
Q4 		$6.92M Sell
7,883
-184
-2% -$152K 1.92% 9
2023
Q3 		$6.64M Sell
8,067
-54
-0.7% -$42.4K 1.94% 9
2023
Q2 		$5.84M Sell
8,121
-20
-0.2% -$15.4K 1.72% 10
2023
Q1 		$6.69M Sell
8,141
-57
-0.7% -$43K 2.09% 8
2022
Q4 		$5.91M Sell
8,198
-425
-5% -$314K 2% 7
2022
Q3 		$5.94M Sell
8,623
-243
-3% -$153K 2.21% 6
2022
Q2 		$5.24M Sell
8,866
-20
-0.2% -$13K 1.79% 7
2022
Q1 		$6.21M Sell
8,886
-21
-0.2% -$13.3K 1.85% 9
2021
Q4 		$5.63M Buy
8,907
+1,543
+21% +$949K 1.54% 10
2021
Q3 		$4.46M Buy
7,364
+900
+14% +$559K 1.06% 16
2021
Q2 		$3.61M Sell
6,464
-70
-1% -$35.5K 0.83% 37
2021
Q1 		$3.09M Buy
6,534
+952
+17% +$464K 0.75% 43
2020
Q4 		$2.7M Sell
5,582
-90
-2% -$48.6K 0.71% 45
2020
Q3 		$3.17M Sell
5,672
-55
-1% -$33.3K 0.94% 27
2020
Q2 		$3.57M Sell
5,727
-75
-1% -$42.6K 1.16% 22
2020
Q1 		$2.83M Buy
5,802
+165
+3% +$68.1K 1.07% 29
2019
Q4 		$2.12M Buy
5,637
+50
+0.9% +$16.8K 0.74% 40
2019
Q3 		$1.55M Buy
5,587
+113
+2% +$33.4K 0.5% 52
2019
Q2 		$1.71M Buy
5,474
+238
+5% +$79.2K 0.54% 52
2019
Q1 		$2.15M Hold
5,236
– – 0.61% 42
2018
Q4 		$1.96M Buy
5,236
+755
+17% +$276K 0.74% 39
2018
Q3 		$1.81M Buy
4,481
+38
+0.9% +$14.5K 0.62% 48
2018
Q2 		$1.53M Buy
+4,443
New +$1.39M 0.59% 49

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cutter & Co Brokerage's REGN Position: Q2 2025 in Review

Cutter & Co Brokerage sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 10,838 shares — an estimated $6.87M sold.

Cutter & Co Brokerage first reported a position in REGN in Q2 2018 and held it in 28 quarters. The position peaked at $8.17M in Q2 2024. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Cutter & Co Brokerage reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Cutter & Co Brokerage sold 10,838 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $6.87M.
  • Cutter & Co Brokerage first reported a position in Regeneron Pharmaceuticals in Q2 2018 and held it in 28 quarters.
  • Cutter & Co Brokerage's Regeneron Pharmaceuticals position peaked at $8.17M in Q2 2024.
  • 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Cutter & Co Brokerage's 13F filing for Q2 2025.